An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
Background: Atopic dermatitis (AD), a chronic recurrent inflammatory skin condition primarily affects children. Topical treatment, systemic treatment, and phototherapy are mainstay of treatment. Objectives: Topical corticosteroids (TCS) are the first line therapy for AD but are associated with va...
Main Authors: | Vinodhini R. Mudaliyar, Asha Pathak, Alok Dixit, Sweta Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2020-10-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | http://dpcj.org/index.php/dpc/article/view/1242 |
Similar Items
-
Comparing the effectiveness of topical fluticasone 0.05% cream versus topical tacrolimus 0.1% ointment in pediatric atopic dermatitis: A randomized controlled trial
by: Sanjeev Handa, et al.
Published: (2022-01-01) -
Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study
by: Xia Dou, et al.
Published: (2023-12-01) -
The therapy of atopic dermatitis in acute phase and in remission
by: Arianna Giannetti, et al.
Published: (2024-03-01) -
Atopic dermatitis
by: Sandeep Kapur, et al.
Published: (2018-09-01) -
Topical therapy for atopic dermatitis: A review
by: Khushboo Minni, et al.
Published: (2021-01-01)